ILLUMINA COVIDSEQ
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88983897
- Registration number
- 6913584
- Mark type
- Stylized text
- Filed
- 29 Apr 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 29 Nov 2022
- Attorney of record
- Susan M. Natland
Goods and services
- Class 001 — Chemicals: Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
- Class 005 — Pharmaceuticals: Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19
Owner
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
- Illumina, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 29 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Oct 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 21 Oct 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 20 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE